Litigation Details for INSULIN PRICING LITIGATION (D.N.J. 2023)
✉ Email this page to a colleague
INSULIN PRICING LITIGATION (D.N.J. 2023)
Docket | ⤷ Sign Up | Date Filed | 2023-08-04 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 18:1962 Racketeering (RICO) Act | Assigned To | Brian R. Martinotti |
Jury Demand | None | Referred To | Edward S. Kiel |
Patents | 8,114,833; 8,129,343; 8,536,122 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in INSULIN PRICING LITIGATION
Details for INSULIN PRICING LITIGATION (D.N.J. 2023)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2024-06-07 | 200 | Memorandum | covered by at least one patent: (1) Victoza: see, e.g., U.S. Patent No. 8,114,833; (2) Trulicity: see…, U.S. Patent Nos. 8,114,833; 8,129,343; 8,536,122; and (4) Soliqua: see, e.g., U.S. Patent Nos. RE45,313…the prices they charge on the patented medications. By creating the patent system, Congress has preempted…were covered by patents at the time the State filed the lawsuit and remain under patent,5 and Manufacturers… For patented products, Congress—not the states—is “the promulgator of patent policy.” Id. | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |